RESUMEN
Background: Immune responses to vaccination are a known trigger for a new onset of glomerular disease or disease flare in susceptible individuals. Mass immunization against SARS-CoV-2 in the COVID-19 pandemic provides a unique opportunity to study vaccination-associated autoimmune kidney diseases. In the recent literature, there are several patient reports demonstrating a temporal association of SARS-CoV-2 immunization and kidney diseases. Methods: Here, we present a series of 29 cases of biopsy-proven glomerular disease in patients recently vaccinated against SARS-CoV-2 and identified patients who developed a new onset of IgA nephropathy, minimal change disease, membranous nephropathy, ANCA-associated GN, collapsing glomerulopathy, or diffuse lupus nephritis diagnosed on kidney biopsies postimmunization, as well as recurrent ANCA-associated GN. This included 28 cases of de novo GN within native kidney biopsies and one disease flare in an allograft. Results: The patients with collapsing glomerulopathy were of Black descent and had two APOL1 genomic risk alleles. A brief literature review of patient reports and small series is also provided to include all reported cases to date (n=52). The incidence of induction of glomerular disease in response to SARS-CoV-2 immunization is unknown; however, there was no overall increase in incidence of glomerular disease when compared with the 2 years prior to the COVID-19 pandemic diagnosed on kidney biopsies in our practice. Conclusions: Glomerular disease to vaccination is rare, although it should be monitored as a potential adverse event.
Asunto(s)
COVID-19 , Glomerulonefritis por IGA , Apolipoproteína L1 , Vacunas contra la COVID-19/efectos adversos , Glomerulonefritis por IGA/epidemiología , Humanos , Pandemias , SARS-CoV-2 , Vacunación/efectos adversosRESUMEN
We used behavior and event-related potentials (ERPs) to examine auditory stream segregation in people with schizophrenia and control participants. During each trial, a context pattern was presented, consisting of low (A) and high (B) tones and silence (-) in a repeating ABA- pattern, with a frequency separation (Δf) of 3, 6, or 12 semitones. Next, a test ABA-pattern was presented that always had a 6-semitone Δf. Larger Δf during the context resulted in more perception of two streams and larger N1 and P2 ERPs, but less perception of two streams during the test pattern. These effects of Δf were smaller in schizophrenia. Individuals with schizophrenia also showed a reduced effect of prior perceptual judgments. Overall, the findings demonstrate that people with schizophrenia have abnormalities in segregating sounds. These abnormalities result from difficulties utilizing frequency cues in addition to reduced temporal context effects.
Asunto(s)
Percepción Auditiva/fisiología , Psicología del Esquizofrénico , Estimulación Acústica , Adulto , Antipsicóticos/uso terapéutico , Demografía , Manual Diagnóstico y Estadístico de los Trastornos Mentales , Electroencefalografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Desempeño Psicomotor/fisiología , Esquizofrenia/tratamiento farmacológicoRESUMEN
Administrators of community-based treatment programs are increasingly being required to utilize psychometrically validated instruments to measure the effectiveness of their interventions. However, developers of psychometric measures have often failed to report strategies relevant to the administration of these measures in nontraditional settings outside the therapy office. Moreover, with few exceptions, developers of evidence-based treatments (EBTs) have insufficiently disseminated methods for integrating assessment measures into treatment planning. Therefore, the purpose of this article is to review an assessment methodology that may be utilized to support EBT for individuals who are identified for substance abuse or related problem behaviors. The application of this methodology is demonstrated utilizing Family Behavior Therapy to exemplify "real world" scenarios involving adolescents and adults. Although many of these strategies are evidence supported, most are based on clinical experiences occurring in clinical trials and dissemination efforts within community settings.
Asunto(s)
Terapia Conductista/normas , Terapia Familiar/normas , Trastornos Relacionados con Sustancias/terapia , Adolescente , Adulto , Servicios Comunitarios de Salud Mental , Escolaridad , Medicina Basada en la Evidencia , Familia , Humanos , Relaciones Padres-Hijo , Grupo de Atención al Paciente , Calidad de Vida , Asunción de RiesgosRESUMEN
The current study examined the construct and criterion validity of the Comprehensive Trail Making Test (CTMT) when used to evaluate children and adolescents with traumatic brain injury (TBI). Participants included 100 children and adolescents, 50 who had sustained TBI and 50 normal comparisons (NC). Analyses indicated that the CTMT factor scores were significantly correlated with tests of perceptual organizational ability, processing speed, and motor function and provided support for its construct validity. Additionally, correlations between the various CTMT scores suggested that a different pattern of associations was present in the TBI group compared to the NC group. Finally, the TBI group performed significantly worse (p < .001) on all of the CTMT scores, including each of the five CTMT trails as well as the factor and composite index scores. Results support the construct and criterion validity of the CTMT when used to assess children and adolescents with TBI.